Troponin T, N-Terminal Pro–B-Type Natriuretic Peptide, and Incidence of Stroke
- 1 April 2013
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 44 (4), 961-967
- https://doi.org/10.1161/strokeaha.111.000173
Abstract
Background and Purpose— Increased levels of plasma troponins and natriuretic peptides are associated with increased risk of cardiovascular disease, but only limited information exists on these biomarkers and stroke occurrence. In a prospective epidemiological study, we tested the hypothesis that high-sensitivity troponin T (TnT) and N-terminal pro–B-type natriuretic peptide (NT-proBNP) are associated positively with incidence of stroke. Methods— The Atherosclerosis Risk in Communities (ARIC) Study measured plasma TnT and NT-proBNP in 10 902 men or women initially free of stroke and followed them for a mean of 11.3 years for stroke occurrence (n=507). Results— Both biomarkers were associated positively with total stroke, nonlacunar ischemic, and especially cardioembolic stroke, but not with lacunar or hemorrhagic stroke. For example, after adjustment for prevalent risk factors and cardiac diseases, the hazard ratios (95% CIs) for jointly high values of TnT and NT-proBNP (versus neither biomarker high) were 2.70 (1.92–3.79) for total stroke and 6.26 (3.40–11.5) for cardioembolic stroke. Associations with stroke appeared somewhat stronger for NT-proBNP than TnT. Strikingly, ≈58% of cardioembolic strokes occurred in the highest quintile of prestroke NT-proBNP, and 32% of cardioembolic strokes occurred in participants who had both NT-proBNP in the highest quintile and were known by ARIC to have atrial fibrillation sometime before their cardioembolic stroke occurrence. Conclusions— In the general population, elevated plasma TnT and NT-proBNP concentrations are associated with increased risk of cardioembolic and other nonlacunar ischemic strokes.Keywords
This publication has 28 references indexed in Scilit:
- Brain Natriuretic Peptide Predicts Functional Outcome in Ischemic StrokeStroke, 2012
- N-Terminal Pro-Brain Natriuretic Peptide and Risk of Cardiovascular Events in a Japanese CommunityArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Sensitive Cardiac Troponin T Assay and the Risk of Incident Cardiovascular Disease in Women With and Without Diabetes MellitusCirculation, 2011
- Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities StudyCirculation, 2011
- Relations of Biomarkers of Distinct Pathophysiological Pathways and Atrial Fibrillation Incidence in the CommunityCirculation, 2010
- Assessing the Performance of Prediction ModelsEpidemiology, 2010
- Incidence of atrial fibrillation in whites and African-Americans: The Atherosclerosis Risk in Communities (ARIC) studyAmerican Heart Journal, 2009
- Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patientsEuropean Heart Journal, 2008
- Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKDAmerican Journal of Kidney Diseases, 2008
- N-Terminal Pro-Brain Natriuretic Peptide, C-Reactive Protein, and Urinary Albumin Levels as Predictors of Mortality and Cardiovascular Events in Older AdultsPublished by American Medical Association (AMA) ,2005